| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_390be8b40737dd62f57f366e17a9af5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8390b42a1f75d72df10df8e9149f9ece
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_334de27021ccc1e114e53798e7aabe8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b578093a24fc1792462e9ebde457e35 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate |
2002-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e865e98ea7110789d63abe443b0dbeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb3eb1cf6587232c087469ee88519dd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7ac8235a3f0a0a63311f0dd3e599e89 |
| publicationDate |
2003-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03051313-A2 |
| titleOfInvention |
Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes |
| abstract |
The present invention generally relates to the field of treating oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathone or intracellular levels of at least one Phase II detoxification enzyme in animal tissue. The present invention also relates to the field of protecting a subject from oxidative stress disorders by administering a pharmaceutically effective amount of a compound that elevates the intracellular levels of glutathone or intracellular levels of at least one Phase II detoxification enzyme in the subject. The present invention also relates to a pharmaceutical composition useful for the treatment of oxidative stress disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-MI20121774-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1803468-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014060509-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011190267-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010001096-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005063295-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008111497-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010001096-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7744937-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10925934-B2 |
| priorityDate |
2001-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |